MVision AI deployed to boost speed and accuracy of radiotherapy planning

| Posted on |

tapio-haaja-1080176-unsplash

For radiation oncologists, the laborious task of determining the treatment plan for cancer patients is being simplified and shortened with the application of AI software from Finnish company MVision.

For radiation oncologists, the laborious task of determining the treatment plan for cancer patients is being simplified and shortened with the application of AI software from Finnish company MVision.

Drawing up a detailed treatment plan requires consideration of the size and location of the tumor, as well as possible metastases. Physicians define the radiotherapy target by manually delineating structures onto multiple X-ray image slices. There can be hundreds of images, and dozens of critical tissue structures, which makes for a time-consuming error-prone process. MVision’s software automatically delineates critical tissue structures for a physician to review and approve. 

MVision has now been deployed in two Finnish hospitals, Turku University Hospital (Tyks) and the Docrates Cancer Center in Helsinki, aimed at prostate cancer patients, and will soon accommodate other cancer sites including head and neck cancers, and breast cancer.”

According to CEO of MVision, Mahmudul Hasan, “As the number of cancer patients continues to grow, a critical shortage of skilled hospital staff continues to exist in many European countries. This problem can be alleviated with the help of our AI, while ensuring a high and uniform quality of radiation treatment for all patients, which also helps with the waiting times.”

The most significant source of error in radiation treatment planning comes from the evaluation of the area of treatment. AI-based software produces uniform results and decreases the possibility of human error. The AI is also constantly learning to speed up and improve its delineations of structures.

Established in 2017, MVision is a Finnish company focusing on development of AI software in medical imaging. It is funded by Business Finland and Icebreaker.vc, amongst others, and its collaborators include Turku, Kuopio and Oulu University clinics, Docrates Cancer Center (Helsinki), North Estonia Medical Centre (Tallinn), and National Cancer Center Singapore. Following deployment of its software in Finland, it is now seeking to expand overseas.